logo

For the Inventor, By the Inventor

Essen, Germany

Metin Colpan

This inventor holds 20 USPTO granted patents and 3 published patent applications, primarily in Nucleic Acid Isolation. Top assignees: Qiagen Gmbh, 3M Innovative Properties Company, Diagen Institut Fur Molekular-Biologische, Diagnostik Gmbh. Active years: 1991-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Metin Colpan. Retrieved from https://idiyas.com/inventor/metin-colpan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 80.0

Average Co-Inventor Count = 2.1

ph-index = 15

Forward Citations = 919(Granted Patents)


Location History:

  • Erkrath, DE (1991 - 1997)
  • Essen-Kettwig, DE (1997 - 2003)
  • Essen, DE (1998 - 2012)

Company Filing History:

goldMedal15 out of 269 
 
Qiagen Gmbh
 patents
silverMedal3 out of 22,412 
 
3M Innovative Properties Company
 patents
bronzeMedal1 out of 2 
 
Diagen Institut Fur Molekular-Biologische, Diagnostik Gmbh
 patents
4. 1 out of 1 
 
Diagen Institute Fur Molekularbrologische Diagnostic, Gmbh
 patent
5. 1 out of 1 
 
Oiagen Gmbh
 patent
where one patent can have more than one assignee

Years Active: 1991-2012

Loading Chart...
Areas of Expertise:
Nucleic Acids
Endotoxins
Chromatographic Purification
Gene Therapy
Separation Processes
Cell Components
Transfection Efficiency
Liquid Samples
Double-Stranded Structures
Single-Stranded Structures
Oligonucleotides
Natural Sources
20 patents (USPTO):Explore Patents
1. 8247545 - Device and a process for the isolation of nucleic acids (2012-08-21),
2. 7510826 - Process for the depletion or removal of endotoxins (2009-03-31),
3. 7109322 - Process for the depletion or removal of endotoxins (2006-09-19),
4. 7074916 - Process for the separation of double-stranded/single-stranded nucleic acid structures (2006-07-11),
5. 6946250 - Process for the separation of double-stranded/single-stranded nucleic acid structures (2005-09-20),
6. 6609618 - Device for the isolation of cell components such as nucleic acids from natural sources (2003-08-26),
7. 6383393 - Chromatographic purification and separation process for mixtures of nucleic acids (2002-05-07),
8. 6297371 - Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy (2001-10-02),
9. 6277648 - Process and a device for the isolation of cell components such as nucleic acids from natural sources (2001-08-21),
10. 6274371 - Process and device for the isolation of cell components, such as nucleic acids, from natural sources (2001-08-14),
11. 6180778 - Process for the separation of double-stranded/single-stranded nucleic acid structures (2001-01-30),
12. 6020186 - Device and process for isolating nucleic acids from cell suspensions (2000-02-01),
13. 5990301 - Process for the separation and purification of nucleic acids from (1999-11-23),
14. 5792651 - Enhancement of the transfection efficiency of nucleic acids by using (1998-08-11),
15. 5747663 - Process for the depletion or removal of endotoxins (1998-05-05),

Title: Metin Colpan: Innovator in Nucleic Acid Isolation

Introduction

Metin Colpan is a prominent inventor based in Essen, Germany, recognized for his significant contributions to biotechnology and genetic engineering. With a remarkable portfolio comprising 20 patents, Colpan has made notable advancements in the field of nucleic acid purification and endotoxin removal.

Latest Patents

Among his latest innovations, Colpan developed a unique device and process for the isolation of nucleic acids. This invention describes a method for purifying plasmid or genomic DNA from cellular sources. The device features a hollow body with an inlet and outlet opening, which utilizes different materials based on silica gel. These materials possess distinct adsorption characteristics, optimizing the recovery of nucleic acids effectively.

Additionally, Colpan has pioneered a process for the depletion or removal of endotoxins from therapeutic preparations derived from natural sources. This method employs chromatographic materials to ensure that active ingredients obtained through genetic engineering and biotechnology are safe for therapeutic use.

Career Highlights

Throughout his career, Colpan has held roles at notable companies, including Qiagen GmbH and Minnesota Mining and Manufacturing Company (3M). His work at these institutions has significantly influenced the field of molecular biology and biotechnological research, underscoring his expertise and commitment to innovation.

Collaborations

Colpan has also collaborated with esteemed colleagues such as Joachim Schorr and Petra Feuser. These partnerships have facilitated the development of cutting-edge technologies and enhanced the impact of his patents in the scientific community.

Conclusion

In summary, Metin Colpan stands out as an influential inventor whose patents have laid the groundwork for advancements in biotechnology and nucleic acid research. His innovative approaches continue to drive progress in the industry, highlighting his role as a key figure in modern scientific developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…